With a robotic arm, nine squares, and a strong partnership between public and private actors, children at Odense University Hospital (OUH) are now given the chance to forget about illness for a moment and challenge the hospital’s newest “player” to a game of tic-tac-toe.
CrossingBio is the newest addition to the growing portfolio of life science spinouts from the University of Southern Denmark (SDU). The company is developing a new therapeutic approach for liver fibrosis, a condition affecting millions of people worldwide and still difficult to treat effectively.
The British newspaper Financial Times has published its annual ranking of Europe’s leading startup hubs and accelerator programmes. Once again, Odense Robotics StartUp Fund is included on the list, and stands out as the only robotics-focused incubator to be recognised.
The Odense-based AI startup Velatir has raised DKK 10 million in pre-seed funding to help European companies scale their use of artificial intelligence with greater transparency, governance and control.
The investment round was led by Ugly Duckling Ventures, with participation from Norrsken.
In 2025, a growing number of international drone companies chose Odense as their base for testing and validation, leveraging the unique capabilities of UAS Denmark Test Center located at HCA Airport.
On December 12, Dymak officially opened its new 2,804-square-meter BIG-designed headquarters in Odense. The facility marks a major milestone for the Odense-based company, serving not only as an impressive new home for its employees but also as a striking architectural landmark in the city.
With a fresh injection of 14 million DKK UCL University College is set to transform Denmark’s life science sector by placing Odense firmly on the map as the nation’s innovation powerhouse. As the coordinating hub for a nationwide upskilling initiative, Odense is sending a clear signal to international investors: this is where the future of life science is being shaped.
With Nordic Capital as majority shareholder, Evosep strengthens its global position – and Odense’s role as a rising life science city. The recent acquisition of Evosep by Nordic Capital marks the biggest direct life science exit in EIFO history. It’s a clear signal that Denmark is not just participating in the global health innovation race – we’re building companies that can lead it.
Inverna Therapeutics has been awarded a USD 700,000 research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), one of the world’s leading supporters of Parkinson’s innovation. The funding will help advance Inverna’s next-generation RNA therapy, a new approach aimed at slowing or stopping the progression of Parkinson.
Spaceline is constructing a brand-new headquarters in HCA Airport’s business park to support the company’s rapid international growth. The company expects to expand from 15 to 100 employees by the end of 2026. After several years as a tenant, the Odense-based company Spaceline is now establishing a completely new 1,000 m² headquarters in HCA Airport’s business park.
Quadsat announced in July that it had secured DKK 37 million in a new funding round. The investment will be used to accelerate electronic warfare capabilities, expand the company’s footprint in the defense sector, and advance the development of cutting-edge RF and spectrum analysis solutions.
A high-flying technology from the startup company SKYFRR has the potential to provide everything from environmental monitoring to logistics with a robust, airborne communications platform. The Odense Robotics StartUp Fund has selected SKYFRR for a spot in the robotics incubator at Teknologisk Institut.
Life science consultancy TECQAN has chosen to establish its headquarters in Odense. The company, which specializes in helping life science companies and startups navigate the extensive requirements for regulation, certification, and documentation, has settled in Forskerparken.
The University of Southern Denmark is set to receive a significant boost to its student entrepreneurship and innovation efforts, as the Otto Mønsted Foundation pledges a generous DKK 50 million to establish a new innovation hub on the Odense campus.
Collaboration between hospitals and tech companies is a recipe for results. MedTech Odense works to support employees with ideas that can strengthen operations and be developed commercially. The goal is to bring these ideas to market and investors.